Form D · Pharmaceuticals

ROCHESTER DRUG CO OPERATIVE INC

Rochester, NY · CIK 0001084077

Offering snapshot reported May 26, 2016 · SEC filing

Reported sold
Yet to sell
Offering amount: $1000K
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 26, 2016InitialYet to sellNo comparison0SEC filing
Apr 14, 2015InitialYet to sellNo comparison0SEC filing
Nov 26, 2013InitialYet to sellNo comparison0SEC filing
Nov 10, 2011InitialYet to sellNo comparison0SEC filing
Sep 30, 2010Initial$26,500No comparison1SEC filing
Jul 28, 2009Initial$50,000No comparison2SEC filing
Dec 4, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
04
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-263931

Source: Form D, filed May 26, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Donald Arthur Director
Donald Arthur, Jr. Director
Joseph Brennan Executive
Sally Brooks Director
Christopher K. Casey Director
Michael Cave Director
Laurence F. Doud Executive
Laurence F. Doud, Iii Executive
Stephen Giroux Director, Executive
Sherwood Klein Director, Executive
Richard Klenck Director
Richard Klenk Director
Joseph Lech Director
Boris Mantell Director
J. Scott Miskovsky Director
Garry Mrozek Director
Paul Pagnotta Director
Kim M. Perry Executive
Thomas M. Quinlan Director
Tom Quinlan Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
50 Jet View Drive
Rochester, NY, 14624